1. Home
  2. AURA vs CCIX Comparison

AURA vs CCIX Comparison

Compare AURA & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • CCIX
  • Stock Information
  • Founded
  • AURA 2007
  • CCIX 2023
  • Country
  • AURA United States
  • CCIX United States
  • Employees
  • AURA N/A
  • CCIX N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • CCIX
  • Sector
  • AURA Health Care
  • CCIX
  • Exchange
  • AURA Nasdaq
  • CCIX Nasdaq
  • Market Cap
  • AURA 396.8M
  • CCIX 386.2M
  • IPO Year
  • AURA 2021
  • CCIX 2024
  • Fundamental
  • Price
  • AURA $6.00
  • CCIX $10.55
  • Analyst Decision
  • AURA Strong Buy
  • CCIX
  • Analyst Count
  • AURA 7
  • CCIX 0
  • Target Price
  • AURA $22.29
  • CCIX N/A
  • AVG Volume (30 Days)
  • AURA 283.0K
  • CCIX 148.5K
  • Earning Date
  • AURA 11-11-2025
  • CCIX 11-07-2013
  • Dividend Yield
  • AURA N/A
  • CCIX N/A
  • EPS Growth
  • AURA N/A
  • CCIX N/A
  • EPS
  • AURA N/A
  • CCIX 0.28
  • Revenue
  • AURA N/A
  • CCIX N/A
  • Revenue This Year
  • AURA N/A
  • CCIX N/A
  • Revenue Next Year
  • AURA N/A
  • CCIX N/A
  • P/E Ratio
  • AURA N/A
  • CCIX $37.14
  • Revenue Growth
  • AURA N/A
  • CCIX N/A
  • 52 Week Low
  • AURA $4.35
  • CCIX $10.01
  • 52 Week High
  • AURA $12.38
  • CCIX $11.66
  • Technical
  • Relative Strength Index (RSI)
  • AURA 35.91
  • CCIX 44.27
  • Support Level
  • AURA $5.93
  • CCIX $10.46
  • Resistance Level
  • AURA $6.28
  • CCIX $10.52
  • Average True Range (ATR)
  • AURA 0.25
  • CCIX 0.05
  • MACD
  • AURA -0.03
  • CCIX -0.00
  • Stochastic Oscillator
  • AURA 0.00
  • CCIX 21.43

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About CCIX Churchill Capital Corp IX Ordinary Shares

Churchill Capital Corp IX is a blank check company.

Share on Social Networks: